Mersana Therapeutics Cash from Investing (TTM) Insights

Mersana Therapeutics Inc (MRSN)

2.07 -0.15 (-6.76%) USD | NASDAQ | Jun 14, 16:00

2.075 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
March 31, 2024	45.94M
December 31, 2023	119.88M
September 30, 2023	54.31M
June 30, 2023	-65.96M
March 31, 2023	-150.99M
December 31, 2022	-152.72M
September 30, 2022	-107.44M
June 30, 2022	-91.00M
March 31, 2022	-0.863M
December 31, 2021	-0.648M
September 30, 2021	-0.681M
June 30, 2021	2.17M
March 31, 2021	17.48M
December 31, 2020	37.03M
September 30, 2020	53.72M

Date	Value
June 30, 2020	9.142M
March 31, 2020	-17.99M
December 31, 2019	-27.29M
September 30, 2019	-30.07M
June 30, 2019	32.42M
March 31, 2019	74.42M
December 31, 2018	87.20M
September 30, 2018	60.28M
June 30, 2018	-2.299M
March 31, 2018	-76.26M
December 31, 2017	-99.62M
September 30, 2017	-86.18M
June 30, 2017	-44.39M
March 31, 2017	-1.16M
December 31, 2016	-1.084M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-152.72M

Minimum

Dec 2022

119.88M

Maximum

Dec 2023

-13.68M

Average

-0.6645M

Median

Cash from Investing (TTM) Benchmarks